Pain is common in cancer patients, particularly in the advanced stage of disease when the
prevalence is estimated to be more than 70%[1], contributing to poor physical and emotional …

Melittin (MEL), a major peptide component of bee venom, is an attractive candidate for
cancer therapy. This agent has shown a variety of anti-cancer effects in preclinical cell …

According to a systematic review of the literature, pain prevalence ranges from 33% in
patients after curative treatment to 59% in patients on anticancer treatment and to 64% in …

Graviola (Annona muricata) is a small deciduous tropical evergreen fruit tree, belonging to
the Annonaceae family, and is widely grown and distributed in tropical and subtropical …

Mechanisms of Chemical Carcinogenicity and Mutagenicity: A Review with Implications for
Predictive Toxicology | Chemical Reviews ACS ACS Publications C&EN CAS Find my …

Poor pain assessment is cited as one barrier to the adequate treatment of cancer pain. The
identification of relevant psychosocial factors may improve the assessment of chronic cancer …

The increasing incidence of a variety of cancers after the Second World War confronts
scientists with the question of their origin. In Western countries, expansion and ageing of the …

epigallocatechin-3-gallate (EGCG), the major bioactive catechin in green tea (GT) has been
studied for almost past thirty years as an agent initially for its cancer chemoprevention effects …

According to the World Health Organization (WHO), the incidence of cancer was 12 667 470
new cases in 2008 and, based on projections, it will be> 15 million in 2020 [1]. Consistent …

Cancer is the second leading cause of death in Western countries, just after circulatory
diseases. 1 Despite the considerable efforts and funds devoted to the research on cancer in …